Regeneron’s new antibody cocktail therapy for high risk category patients proves effective

Regeneron has released their antibody cocktail for treating mild to severe cases of COVID-19. Their antibody cocktail consists of casirivimab and imdevimab both of which are monoclonal antibodies which when given together have been shown to have significant anti-viral activity against COVID-19 for patients who are in the high risk category (defined extensively here) forContinue reading “Regeneron’s new antibody cocktail therapy for high risk category patients proves effective”

mRNA vaccines: Concept of the future to reality in 8 months

mRNA vaccines were always a promise of the future. They would be easy to produce and can be made rather quickly. Not that long ago, the promise of an RNA vaccine coming into fruition was still a few years away, progress wasn’t slow but there was no urgency, we would take our time to studyContinue reading “mRNA vaccines: Concept of the future to reality in 8 months”